$410 Million is the total value of Canaan Partners IX LLC's 2 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ARVN | Sell | Arvinas Inc | $304,861,000 | +223.7% | 3,589,554 | -10.0% | 74.36% | -25.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-02
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Arvinas Inc | 11 | Q2 2022 | 100.0% |
CytomX Therapeutics, Inc. | 4 | Q3 2016 | 100.0% |
The RealReal Inc | 3 | Q2 2020 | 47.4% |
None | 3 | Q2 2024 | 0.0% |
LIGHTSPEED POS INC | 2 | Q1 2021 | 28.3% |
MAPLEBEAR INC | 1 | Q4 2023 | 100.0% |
View Canaan Partners IX LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-07-09 |
13F-HR | 2024-04-05 |
13F-HR | 2024-02-01 |
13F-HR | 2023-02-01 |
13F-HR | 2022-08-10 |
13F-HR | 2022-04-28 |
13F-HR | 2022-02-03 |
13F-HR | 2021-11-15 |
13F-HR | 2021-07-22 |
13F-HR | 2021-05-03 |
View Canaan Partners IX LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.